Overview

A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract

Status:
Recruiting

Trial end date:
2022-10-30

Target enrollment:

Participant gender:

Summary

To assess the safety of Dextenza compared to an active control, prednisolone acetate suspension, for the treatment of postoperative pain and inflammation following ocular surgery for pediatric cataract.

Phase:

Phase 3

Details

Lead Sponsor:

Ocular Therapeutix, Inc.

Treatments:

Prednisolone